Cell-mediated Delivery of Nanoformulated Antioxidants for Treatment of Neurodegenerative Disorders

2014-09-16 00:00:00

Elena V. Batrakova talks about "Cell-mediated Delivery of Nanoformulated Antioxidants for Treatment of Neurodegenerative Disorders" at the 2014 Nanotechnology for Health Care Conference put on by the Winthrop Rockefeller Institute.




Dr. Batrakova mentors graduate students and teaches in Innovative Drug Delivery (PHSC851).

Research Activities/Interests:
The main focus of Dr. Batrakova's research is development of developing a cell-mediated active delivery of therapeutic polypeptides to the brain for treatment of Parkinson's Disease using inflammatory-response cells as vehicles. Dr. Batrakova is also devoted to the development of a new drug delivery polymer-based system of chemotherapy to treat multi-drug resistant (MDR) tumors, and CNS disorders.

Elena V. Batrakova talks about "Cell-mediated Delivery of Nanoformulated Antioxidants for Treatment of Neurodegenerative Disorders" at the 2014 Nanotechnology for Health Care Conference put on by the Winthrop Rockefeller Institute.




Dr. Batrakova mentors graduate students and teaches in Innovative Drug Delivery (PHSC851).

Research Activities/Interests:
The main focus of Dr. Batrakova's research is development of developing a cell-mediated active delivery of therapeutic polypeptides to the brain for treatment of Parkinson's Disease using inflammatory-response cells as vehicles. Dr. Batrakova is also devoted to the development of a new drug delivery polymer-based system of chemotherapy to treat multi-drug resistant (MDR) tumors, and CNS disorders.

http://www.youtube.com/watch?v=wMApyA50m7sindex